|
Quotes & Info
|
| CTSO > SEC Filings for CTSO > Form 8-K on 11-Feb-2013 | All Recent SEC Filings |
11-Feb-2013
Change in Directors or Principal Officers, Other Events, Financial Statements a
Effective February 8, 2013, Thomas Bocchino, Chief Financial Officer of Cytosorbents Corporation (the "Company"), resigned from his position with the Company. The resignation of Mr. Bocchino was not a result of any disagreements relating to the Company's operations, policies or practices. Mr. Bocchino has agreed to stay on part-time with the Company. Furthermore, the terms and obligations of Mr. Bocchino's employment agreement shall remain in effect for a period of thirty (30) days from Mr. Bocchino's resignation.
On the same day, the Board of Directors of the Company appointed Ronald Berger as the interim Chief Financial Officer until a new Chief Financial Officer is appointed.
Mr. Berger, 69, has performed many roles in accounting and finance, including serving as Vice President of Finance and Administration of Quick Chek Corporation and Controller of Singer Supermarkets, a member of ShopRite Supermarkets. He is a certified public accountant experienced in treasury, finance and taxes. Mr. Berger has been the Controller for the Company over the past nine years and has extensive experience in the public administration of the Company.
Family Relationships
There are no family relationships between Mr. Berger and any previous officers or directors of the Company.
Related Party Transactions
There are no related party transactions reportable under Item 5.02 of Form 8-K or Item 404(a) of Regulation S-K.
Employment Agreements
The Company does not have any employment agreement with Mr. Berger.
Change in Chief Financial Officer
On February 8, 2013, the Company issued a press release announcing Mr. Bocchino's resignation and the appointment of Mr. Berger as the interim Chief Financial Officer, a copy of which is attached as Exhibit 99.1 to this Current Report on Form 8-K.
(d) Exhibits
Exhibit Number Description of Exhibit
99.1 Press Release Dated February 8, 2013 , "CytoSorbents Appoints
Ronald Berger as Interim Chief Financial Officer"
|
|
|